查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1739337

全球數位基因組學市場

Digital Genomes
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 184 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

預計到 2030 年全球數位基因組學市場規模將達到 728 億美元

全球數位基因組學市場規模預計在2024年為337億美元，預計到2030年將達到728億美元，2024年至2030年的複合年成長率為13.7%。定序和分析儀器是本報告分析的細分市場之一，預計其複合年成長率為16.1%，到分析期結束時規模將達到318億美元。 DNA/RNA分析套件細分市場在分析期間的複合年成長率預計為11.3%。

美國市場規模估計為 89 億美元，中國市場預計複合年成長率為 12.8%

美國數位基因組學市場規模預計在2024年達到89億美元。作為世界第二大經濟體，中國預計到2030年市場規模將達到112億美元，在2024-2030年的分析期間內，複合年成長率為12.8%。其他值得關注的區域市場包括日本和加拿大，預計在分析期間內，這兩個市場的複合年成長率分別為13.0%和11.5%。在歐洲，預計德國市場的複合年成長率約為9.8%。

全球數位基因組學市場—主要趨勢和促進因素摘要

精準醫療會進入數位基因組時代嗎？

數位基因組——虛擬呈現個體的完整遺傳密碼，利用先進的運算系統進行儲存和分析——正在徹底改變個人化醫療、藥物開發和疾病預防的模式。全球數位基因組市場由次世代定序儀(NGS)、人工智慧驅動的生物資訊學和雲端基礎資料儲存的融合驅動，實現快速、可擴展且經濟高效的基因分析。

一個決定性趨勢是從孤立的基因檢測轉向整合的數位基因組平台，該平台將原始DNA數據、表現型關聯、健康記錄和即時監測整合到一個統一的介面。此類平台在腫瘤學、罕見疾病診斷、藥物基因組學和群體基因組學領域的應用日益廣泛。美國、英國和中國等國家正在投資國家基因組圖譜繪製計劃，推動數據豐富、雲端安全的數位基因組基礎設施的普及。

科技融合將如何釋放基因組學的潛力？

人工智慧和機器學習演算法是數位基因組革命的核心，有助於快速檢測變異、建立風險模型並識別治療標靶。這些技術正在幫助臨床醫生解讀複雜的基因組資料集並匹配最佳治療方案。此外，透過整合到穿戴式裝置中的健康數據即時更新個人基因組圖譜也正在成為可能，尤其是在縱向健康研究中。

儲存和加密技術的進步也使得基因資料的安全共用成為可能。人們正在探索聯合數據模型和區塊鏈，以實現基因組數據的去中心化訪問，同時又不損害患者隱私。病患隱私是歐盟《一般資料保護規範》（GDPR）和美國《健康保險流通與責任法案》（HIPAA）等法規環境下關注的關鍵議題。

哪些市場和最終用戶的需求正在加速成長？

數位基因組學市場在北美和歐洲迅速擴張，而亞太地區則因政府支持的基因組定序計畫和不斷發展的生物技術生態系統而逐漸成為戰略成長前沿。終端用戶包括學術研究機構、醫院、生物製藥公司、直接面對消費者 (DTC) 的基因檢測提供者以及健康保險公司。

英國的十萬基因組計劃和美國國立衛生研究院的「我們所有人」研究計畫等人口健康計畫是主要的成長舉措，而私人基因檢測公司正在推出面向消費者的基因組儀表板，將遺傳風險與生活方式和健康干預聯繫起來。

推動數位基因組學市場成長的因素是什麼？

數位基因組學市場的成長是由基因組學、人工智慧分析和精準醫療需求的共同推動的。全基因組定序價格的上漲以及雲端運算的便利化，促使越來越多的醫療機構採用數位基因體學平台。

醫療保健系統正在認知到基因組學在風險分層和早期療育的價值，尤其是在腫瘤學、心臟病學和神經病學領域。製藥公司正在利用數位基因組資料集來識別新的藥物標靶，並根據基因反應對試驗參與者進行分層。監管的明確性和數據共用的全球合作正在進一步促進數位基因組學融入主流醫學。

部分

產品（定序與分析儀、DNA/RNA分析套件、定序晶片、定序與分析軟體、樣本製備儀器）、應用（臨床、法醫學、藥物研發、其他應用）、最終用戶（醫院、診斷中心和法醫學實驗室、研發、其他最終用戶）

受訪公司範例（44家值得關注的公司）

  • 10x Genomics
  • Agilent Technologies, Inc.
  • ArcherDx, Inc.
  • BGI Genomics
  • bioMerieux SA
  • Bio-Rad Laboratories, Inc.
  • Eurofins Scientific SE
  • Fabric Genomics, Inc.
  • Foundation Medicine, Inc.
  • Genewiz
  • Guardant Health, Inc.
  • Illumina, Inc.
  • Invitae Corporation
  • Myriad Genetics, Inc.
  • NanoString Technologies, Inc.
  • Oxford Nanopore Technologies Ltd.
  • Pacific Biosciences of California, Inc.
  • PerkinElmer, Inc.
  • QIAGEN NV
  • Thermo Fisher Scientific Inc.

關稅影響係數

全球產業分析師根據公司總部所在國家、製造地、進出口（成品和原始OEM）來預測其競爭地位的變化。這種複雜且多面向的市場動態預計將以多種方式影響競爭對手，包括人為提高銷貨成本、盈利下降、供應鏈重組以及其他微觀和宏觀市場動態。

全球產業分析師密切關注來自全球頂尖首席經濟學家（14,949位）、智庫（62家）以及貿易和產業協會（171家）的專家的意見，以評估其對生態系統的影響並應對新的市場現實。我們追蹤了來自每個主要國家的專家和經濟學家對關稅及其對本國影響的看法。

全球產業分析師預計，這場動盪將在未來2-3個月內逐漸平息，新的世界秩序將更加清晰地建立。全球產業分析師正在即時追蹤這些事態發展。

2025年4月：談判階段

在4月的報告中，我們將探討關稅對全球整體市場的影響，並提供區域市場調整。我們的預測是基於歷史數據和不斷變化的市場影響因素。

2025年7月：最終關稅調整

在各國宣布最終重置後，客戶將在 7 月收到免費更新，最終更新將包含明確的關稅影響分析。

相互和雙邊貿易及關稅影響分析：

美國<>中國<>墨西哥<>加拿大<>歐盟<>日本<>印度<>其他176個國家

領先的產業經濟學家：全球產業分析師知識庫追蹤了 14,949 位經濟學家，其中包括來自民族國家、智庫、貿易和產業協會、大型企業以及各領域專家的最具影響力的首席經濟學家，他們共用了這場前所未有的全球經濟狀況模式轉移的影響。我們超過 16,491 份報告大多遵循基於里程碑的兩階段發布計劃。

目錄

第1章調查方法

第2章執行摘要

  • 市場概覽
  • 主要企業
  • 市場趨勢和促進因素
  • 全球市場展望

第3章市場分析

  • 美國
  • 加拿大
  • 日本
  • 中國
  • 歐洲
  • 法國
  • 德國
  • 義大利
  • 英國
  • 其他歐洲國家
  • 亞太地區
  • 其他地區

第4章 競賽

簡介目錄
Product Code: MCP33720

Global Digital Genomes Market to Reach US$72.8 Billion by 2030

The global market for Digital Genomes estimated at US$33.7 Billion in the year 2024, is expected to reach US$72.8 Billion by 2030, growing at a CAGR of 13.7% over the analysis period 2024-2030. Sequencing & Analyzer Instruments, one of the segments analyzed in the report, is expected to record a 16.1% CAGR and reach US$31.8 Billion by the end of the analysis period. Growth in the DNA / RNA Analysis Kits segment is estimated at 11.3% CAGR over the analysis period.

The U.S. Market is Estimated at US$8.9 Billion While China is Forecast to Grow at 12.8% CAGR

The Digital Genomes market in the U.S. is estimated at US$8.9 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$11.2 Billion by the year 2030 trailing a CAGR of 12.8% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 13.0% and 11.5% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 9.8% CAGR.

Global Digital Genomes Market - Key Trends & Drivers Summarized

Is Precision Health Entering the Age of the Digital Genome?

Digital genomes-virtual representations of an individual’s complete genetic code stored and analyzed using advanced computing systems-are transforming the landscape of personalized medicine, drug development, and disease prevention. The global market for digital genomes is being driven by the convergence of next-generation sequencing (NGS), AI-enabled bioinformatics, and cloud-based data storage, enabling rapid, scalable, and cost-effective genetic analysis.

A defining trend is the shift from siloed genetic testing to integrated digital genome platforms, which consolidate raw DNA data, phenotype linkage, health records, and real-time monitoring into unified interfaces. These platforms are finding increasing use in oncology, rare disease diagnostics, pharmacogenomics, and population genomics initiatives. Countries such as the U.S., U.K., and China are investing in national-scale genome mapping projects, boosting the adoption of data-rich, cloud-secure digital genome infrastructure.

How Are Technological Convergences Unlocking Genomic Potential?

AI and machine learning algorithms are central to the digital genome revolution, facilitating rapid variant detection, risk modeling, and therapeutic target identification. These technologies are helping clinicians interpret complex genomic datasets and match them with optimal treatments-ushering in an era of predictive and preventive medicine. Moreover, real-time updates to individual genome profiles via wearable-integrated health data are becoming possible, especially in longitudinal health studies.

Advancements in storage and encryption technologies are also making secure sharing of genetic data feasible. Federated data models and blockchain are being explored to allow decentralized access to genomic data without compromising patient privacy, a key concern in regulated environments like the EU under GDPR or the U.S. under HIPAA.

Where Is Demand Accelerating and Who Are the End-Users?

The digital genome market is expanding rapidly in North America and Europe, with Asia-Pacific emerging as a strategic growth frontier due to government-backed genome sequencing programs and expanding biotech ecosystems. End-users include academic research institutions, hospitals, biopharmaceutical companies, direct-to-consumer (DTC) genetic testing providers, and health insurers.

Population health initiatives-such as the UK's 100,000 Genomes Project or the NIH's All of Us research program-are key growth catalysts, while private genetic testing companies are deploying consumer-facing genome dashboards to connect genetic risk with lifestyle and wellness interventions.

What’s Driving Growth in the Digital Genomes Market?

The growth in the digital genomes market is driven by a confluence of genomic science, AI analytics, and demand for precision medicine. Rising affordability of whole genome sequencing, along with increased accessibility to cloud computing, is enabling more institutions to adopt digital genome platforms.

Healthcare systems are recognizing the value of genomics in risk stratification and early intervention, particularly in oncology, cardiology, and neurology. Pharmaceutical firms are using digital genome datasets to identify novel drug targets and stratify trial participants based on genetic responsiveness. Regulatory clarity and global collaborations on data sharing are further fueling the integration of digital genomes into mainstream medicine.

SCOPE OF STUDY:

The report analyzes the Digital Genomes market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Product (Sequencing & Analyzer Instruments, DNA / RNA Analysis Kits, Sequencing Chips, Sequencing & Analysis Software, Sample Preparation Instruments); Application (Clinical, Forensics, Drug Discovery & Development, Other Applications); End-User (Hospitals, Diagnostic Centers & Forensic Labs, Research Institutes, Other End-Users)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.

Select Competitors (Total 44 Featured) -

  • 10x Genomics
  • Agilent Technologies, Inc.
  • ArcherDx, Inc.
  • BGI Genomics
  • bioMerieux SA
  • Bio-Rad Laboratories, Inc.
  • Eurofins Scientific SE
  • Fabric Genomics, Inc.
  • Foundation Medicine, Inc.
  • Genewiz
  • Guardant Health, Inc.
  • Illumina, Inc.
  • Invitae Corporation
  • Myriad Genetics, Inc.
  • NanoString Technologies, Inc.
  • Oxford Nanopore Technologies Ltd.
  • Pacific Biosciences of California, Inc.
  • PerkinElmer, Inc.
  • QIAGEN N.V.
  • Thermo Fisher Scientific Inc.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by artificially increasing the COGS, reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

We are diligently following expert opinions of leading Chief Economists (14,949), Think Tanks (62), Trade & Industry bodies (171) worldwide, as they assess impact and address new market realities for their ecosystems. Experts and economists from every major country are tracked for their opinions on tariffs and how they will impact their countries.

We expect this chaos to play out over the next 2-3 months and a new world order is established with more clarity. We are tracking these developments on a real time basis.

As we release this report, U.S. Trade Representatives are pushing their counterparts in 183 countries for an early closure to bilateral tariff negotiations. Most of the major trading partners also have initiated trade agreements with other key trading nations, outside of those in the works with the United States. We are tracking such secondary fallouts as supply chains shift.

To our valued clients, we say, we have your back. We will present a simplified market reassessment by incorporating these changes!

APRIL 2025: NEGOTIATION PHASE

Our April release addresses the impact of tariffs on the overall global market and presents market adjustments by geography. Our trajectories are based on historic data and evolving market impacting factors.

JULY 2025 FINAL TARIFF RESET

Complimentary Update: Our clients will also receive a complimentary update in July after a final reset is announced between nations. The final updated version incorporates clearly defined Tariff Impact Analyses.

Reciprocal and Bilateral Trade & Tariff Impact Analyses:

USA <> CHINA <> MEXICO <> CANADA <> EU <> JAPAN <> INDIA <> 176 OTHER COUNTRIES.

Leading Economists - Our knowledge base tracks 14,949 economists including a select group of most influential Chief Economists of nations, think tanks, trade and industry bodies, big enterprises, and domain experts who are sharing views on the fallout of this unprecedented paradigm shift in the global econometric landscape. Most of our 16,491+ reports have incorporated this two-stage release schedule based on milestones.

COMPLIMENTARY PREVIEW

Contact your sales agent to request an online 300+ page complimentary preview of this research project. Our preview will present full stack sources, and validated domain expert data transcripts. Deep dive into our interactive data-driven online platform.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Impact of Covid-19 and a Looming Global Recession
    • Digital Genomes - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Advances in Genomic Sequencing Technologies Propel Demand for Digital Genome Platforms
    • Rising Use of AI in Genomic Data Interpretation Accelerates Clinical Application of Digital Genomes
    • Personalized Medicine Trends Strengthen Business Case for Genome Digitization
    • Integration of Genomic Data with EHR Systems Enhances Predictive Healthcare Models
    • Growing Demand for Population-Wide Genomic Screening Expands Digital Genome Infrastructure Investment
    • Increased Focus on Rare Disease Diagnosis Drives Adoption of Comprehensive Genomic Databases
    • Data Privacy Regulations in Genomics Create Both Challenges and Opportunities for Secure Platform Development
    • Collaborations Between Biotech Firms and Cloud Providers Spur Innovation in Scalable Genome Data Storage
    • Pharma R&D Shifts Toward Genotype-Driven Drug Discovery Highlights Need for Digital Genome Platforms
    • Public Health Genomics Programs in Asia and Europe Generate Long-Term Growth Opportunities
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Digital Genomes Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Digital Genomes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 3: World 6-Year Perspective for Digital Genomes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2025 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Sequencing & Analyzer Instruments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 5: World 6-Year Perspective for Sequencing & Analyzer Instruments by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 6: World Recent Past, Current & Future Analysis for DNA / RNA Analysis Kits by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 7: World 6-Year Perspective for DNA / RNA Analysis Kits by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Sequencing Chips by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 9: World 6-Year Perspective for Sequencing Chips by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Sequencing & Analysis Software by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 11: World 6-Year Perspective for Sequencing & Analysis Software by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 12: World Recent Past, Current & Future Analysis for Sample Preparation Instruments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 13: World 6-Year Perspective for Sample Preparation Instruments by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 15: World 6-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 16: World Recent Past, Current & Future Analysis for Diagnostic Centers & Forensic Labs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 17: World 6-Year Perspective for Diagnostic Centers & Forensic Labs by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 18: World Recent Past, Current & Future Analysis for Research Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 19: World 6-Year Perspective for Research Institutes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Other End-Users by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 21: World 6-Year Perspective for Other End-Users by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 22: World Recent Past, Current & Future Analysis for Clinical by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 23: World 6-Year Perspective for Clinical by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 24: World Recent Past, Current & Future Analysis for Forensics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 25: World 6-Year Perspective for Forensics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Drug Discovery & Development by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 27: World 6-Year Perspective for Drug Discovery & Development by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 28: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 29: World 6-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Digital Genomes Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 30: USA Recent Past, Current & Future Analysis for Digital Genomes by Product - Sequencing & Analyzer Instruments, DNA / RNA Analysis Kits, Sequencing Chips, Sequencing & Analysis Software and Sample Preparation Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 31: USA 6-Year Perspective for Digital Genomes by Product - Percentage Breakdown of Value Sales for Sequencing & Analyzer Instruments, DNA / RNA Analysis Kits, Sequencing Chips, Sequencing & Analysis Software and Sample Preparation Instruments for the Years 2025 & 2030
    • TABLE 32: USA Recent Past, Current & Future Analysis for Digital Genomes by End-user - Hospitals, Diagnostic Centers & Forensic Labs, Research Institutes and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 33: USA 6-Year Perspective for Digital Genomes by End-user - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers & Forensic Labs, Research Institutes and Other End-Users for the Years 2025 & 2030
    • TABLE 34: USA Recent Past, Current & Future Analysis for Digital Genomes by Application - Clinical, Forensics, Drug Discovery & Development and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 35: USA 6-Year Perspective for Digital Genomes by Application - Percentage Breakdown of Value Sales for Clinical, Forensics, Drug Discovery & Development and Other Applications for the Years 2025 & 2030
  • CANADA
    • TABLE 36: Canada Recent Past, Current & Future Analysis for Digital Genomes by Product - Sequencing & Analyzer Instruments, DNA / RNA Analysis Kits, Sequencing Chips, Sequencing & Analysis Software and Sample Preparation Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 37: Canada 6-Year Perspective for Digital Genomes by Product - Percentage Breakdown of Value Sales for Sequencing & Analyzer Instruments, DNA / RNA Analysis Kits, Sequencing Chips, Sequencing & Analysis Software and Sample Preparation Instruments for the Years 2025 & 2030
    • TABLE 38: Canada Recent Past, Current & Future Analysis for Digital Genomes by End-user - Hospitals, Diagnostic Centers & Forensic Labs, Research Institutes and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 39: Canada 6-Year Perspective for Digital Genomes by End-user - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers & Forensic Labs, Research Institutes and Other End-Users for the Years 2025 & 2030
    • TABLE 40: Canada Recent Past, Current & Future Analysis for Digital Genomes by Application - Clinical, Forensics, Drug Discovery & Development and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 41: Canada 6-Year Perspective for Digital Genomes by Application - Percentage Breakdown of Value Sales for Clinical, Forensics, Drug Discovery & Development and Other Applications for the Years 2025 & 2030
  • JAPAN
    • Digital Genomes Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 42: Japan Recent Past, Current & Future Analysis for Digital Genomes by Product - Sequencing & Analyzer Instruments, DNA / RNA Analysis Kits, Sequencing Chips, Sequencing & Analysis Software and Sample Preparation Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 43: Japan 6-Year Perspective for Digital Genomes by Product - Percentage Breakdown of Value Sales for Sequencing & Analyzer Instruments, DNA / RNA Analysis Kits, Sequencing Chips, Sequencing & Analysis Software and Sample Preparation Instruments for the Years 2025 & 2030
    • TABLE 44: Japan Recent Past, Current & Future Analysis for Digital Genomes by End-user - Hospitals, Diagnostic Centers & Forensic Labs, Research Institutes and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 45: Japan 6-Year Perspective for Digital Genomes by End-user - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers & Forensic Labs, Research Institutes and Other End-Users for the Years 2025 & 2030
    • TABLE 46: Japan Recent Past, Current & Future Analysis for Digital Genomes by Application - Clinical, Forensics, Drug Discovery & Development and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 47: Japan 6-Year Perspective for Digital Genomes by Application - Percentage Breakdown of Value Sales for Clinical, Forensics, Drug Discovery & Development and Other Applications for the Years 2025 & 2030
  • CHINA
    • Digital Genomes Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 48: China Recent Past, Current & Future Analysis for Digital Genomes by Product - Sequencing & Analyzer Instruments, DNA / RNA Analysis Kits, Sequencing Chips, Sequencing & Analysis Software and Sample Preparation Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 49: China 6-Year Perspective for Digital Genomes by Product - Percentage Breakdown of Value Sales for Sequencing & Analyzer Instruments, DNA / RNA Analysis Kits, Sequencing Chips, Sequencing & Analysis Software and Sample Preparation Instruments for the Years 2025 & 2030
    • TABLE 50: China Recent Past, Current & Future Analysis for Digital Genomes by End-user - Hospitals, Diagnostic Centers & Forensic Labs, Research Institutes and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 51: China 6-Year Perspective for Digital Genomes by End-user - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers & Forensic Labs, Research Institutes and Other End-Users for the Years 2025 & 2030
    • TABLE 52: China Recent Past, Current & Future Analysis for Digital Genomes by Application - Clinical, Forensics, Drug Discovery & Development and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 53: China 6-Year Perspective for Digital Genomes by Application - Percentage Breakdown of Value Sales for Clinical, Forensics, Drug Discovery & Development and Other Applications for the Years 2025 & 2030
  • EUROPE
    • Digital Genomes Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 54: Europe Recent Past, Current & Future Analysis for Digital Genomes by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 55: Europe 6-Year Perspective for Digital Genomes by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2025 & 2030
    • TABLE 56: Europe Recent Past, Current & Future Analysis for Digital Genomes by Product - Sequencing & Analyzer Instruments, DNA / RNA Analysis Kits, Sequencing Chips, Sequencing & Analysis Software and Sample Preparation Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Europe 6-Year Perspective for Digital Genomes by Product - Percentage Breakdown of Value Sales for Sequencing & Analyzer Instruments, DNA / RNA Analysis Kits, Sequencing Chips, Sequencing & Analysis Software and Sample Preparation Instruments for the Years 2025 & 2030
    • TABLE 58: Europe Recent Past, Current & Future Analysis for Digital Genomes by End-user - Hospitals, Diagnostic Centers & Forensic Labs, Research Institutes and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 59: Europe 6-Year Perspective for Digital Genomes by End-user - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers & Forensic Labs, Research Institutes and Other End-Users for the Years 2025 & 2030
    • TABLE 60: Europe Recent Past, Current & Future Analysis for Digital Genomes by Application - Clinical, Forensics, Drug Discovery & Development and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 61: Europe 6-Year Perspective for Digital Genomes by Application - Percentage Breakdown of Value Sales for Clinical, Forensics, Drug Discovery & Development and Other Applications for the Years 2025 & 2030
  • FRANCE
    • Digital Genomes Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 62: France Recent Past, Current & Future Analysis for Digital Genomes by Product - Sequencing & Analyzer Instruments, DNA / RNA Analysis Kits, Sequencing Chips, Sequencing & Analysis Software and Sample Preparation Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 63: France 6-Year Perspective for Digital Genomes by Product - Percentage Breakdown of Value Sales for Sequencing & Analyzer Instruments, DNA / RNA Analysis Kits, Sequencing Chips, Sequencing & Analysis Software and Sample Preparation Instruments for the Years 2025 & 2030
    • TABLE 64: France Recent Past, Current & Future Analysis for Digital Genomes by End-user - Hospitals, Diagnostic Centers & Forensic Labs, Research Institutes and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 65: France 6-Year Perspective for Digital Genomes by End-user - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers & Forensic Labs, Research Institutes and Other End-Users for the Years 2025 & 2030
    • TABLE 66: France Recent Past, Current & Future Analysis for Digital Genomes by Application - Clinical, Forensics, Drug Discovery & Development and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 67: France 6-Year Perspective for Digital Genomes by Application - Percentage Breakdown of Value Sales for Clinical, Forensics, Drug Discovery & Development and Other Applications for the Years 2025 & 2030
  • GERMANY
    • Digital Genomes Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 68: Germany Recent Past, Current & Future Analysis for Digital Genomes by Product - Sequencing & Analyzer Instruments, DNA / RNA Analysis Kits, Sequencing Chips, Sequencing & Analysis Software and Sample Preparation Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Germany 6-Year Perspective for Digital Genomes by Product - Percentage Breakdown of Value Sales for Sequencing & Analyzer Instruments, DNA / RNA Analysis Kits, Sequencing Chips, Sequencing & Analysis Software and Sample Preparation Instruments for the Years 2025 & 2030
    • TABLE 70: Germany Recent Past, Current & Future Analysis for Digital Genomes by End-user - Hospitals, Diagnostic Centers & Forensic Labs, Research Institutes and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 71: Germany 6-Year Perspective for Digital Genomes by End-user - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers & Forensic Labs, Research Institutes and Other End-Users for the Years 2025 & 2030
    • TABLE 72: Germany Recent Past, Current & Future Analysis for Digital Genomes by Application - Clinical, Forensics, Drug Discovery & Development and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 73: Germany 6-Year Perspective for Digital Genomes by Application - Percentage Breakdown of Value Sales for Clinical, Forensics, Drug Discovery & Development and Other Applications for the Years 2025 & 2030
  • ITALY
    • TABLE 74: Italy Recent Past, Current & Future Analysis for Digital Genomes by Product - Sequencing & Analyzer Instruments, DNA / RNA Analysis Kits, Sequencing Chips, Sequencing & Analysis Software and Sample Preparation Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Italy 6-Year Perspective for Digital Genomes by Product - Percentage Breakdown of Value Sales for Sequencing & Analyzer Instruments, DNA / RNA Analysis Kits, Sequencing Chips, Sequencing & Analysis Software and Sample Preparation Instruments for the Years 2025 & 2030
    • TABLE 76: Italy Recent Past, Current & Future Analysis for Digital Genomes by End-user - Hospitals, Diagnostic Centers & Forensic Labs, Research Institutes and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 77: Italy 6-Year Perspective for Digital Genomes by End-user - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers & Forensic Labs, Research Institutes and Other End-Users for the Years 2025 & 2030
    • TABLE 78: Italy Recent Past, Current & Future Analysis for Digital Genomes by Application - Clinical, Forensics, Drug Discovery & Development and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 79: Italy 6-Year Perspective for Digital Genomes by Application - Percentage Breakdown of Value Sales for Clinical, Forensics, Drug Discovery & Development and Other Applications for the Years 2025 & 2030
  • UNITED KINGDOM
    • Digital Genomes Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 80: UK Recent Past, Current & Future Analysis for Digital Genomes by Product - Sequencing & Analyzer Instruments, DNA / RNA Analysis Kits, Sequencing Chips, Sequencing & Analysis Software and Sample Preparation Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 81: UK 6-Year Perspective for Digital Genomes by Product - Percentage Breakdown of Value Sales for Sequencing & Analyzer Instruments, DNA / RNA Analysis Kits, Sequencing Chips, Sequencing & Analysis Software and Sample Preparation Instruments for the Years 2025 & 2030
    • TABLE 82: UK Recent Past, Current & Future Analysis for Digital Genomes by End-user - Hospitals, Diagnostic Centers & Forensic Labs, Research Institutes and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 83: UK 6-Year Perspective for Digital Genomes by End-user - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers & Forensic Labs, Research Institutes and Other End-Users for the Years 2025 & 2030
    • TABLE 84: UK Recent Past, Current & Future Analysis for Digital Genomes by Application - Clinical, Forensics, Drug Discovery & Development and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 85: UK 6-Year Perspective for Digital Genomes by Application - Percentage Breakdown of Value Sales for Clinical, Forensics, Drug Discovery & Development and Other Applications for the Years 2025 & 2030
  • REST OF EUROPE
    • TABLE 86: Rest of Europe Recent Past, Current & Future Analysis for Digital Genomes by Product - Sequencing & Analyzer Instruments, DNA / RNA Analysis Kits, Sequencing Chips, Sequencing & Analysis Software and Sample Preparation Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Rest of Europe 6-Year Perspective for Digital Genomes by Product - Percentage Breakdown of Value Sales for Sequencing & Analyzer Instruments, DNA / RNA Analysis Kits, Sequencing Chips, Sequencing & Analysis Software and Sample Preparation Instruments for the Years 2025 & 2030
    • TABLE 88: Rest of Europe Recent Past, Current & Future Analysis for Digital Genomes by End-user - Hospitals, Diagnostic Centers & Forensic Labs, Research Institutes and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 89: Rest of Europe 6-Year Perspective for Digital Genomes by End-user - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers & Forensic Labs, Research Institutes and Other End-Users for the Years 2025 & 2030
    • TABLE 90: Rest of Europe Recent Past, Current & Future Analysis for Digital Genomes by Application - Clinical, Forensics, Drug Discovery & Development and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 91: Rest of Europe 6-Year Perspective for Digital Genomes by Application - Percentage Breakdown of Value Sales for Clinical, Forensics, Drug Discovery & Development and Other Applications for the Years 2025 & 2030
  • ASIA-PACIFIC
    • Digital Genomes Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 92: Asia-Pacific Recent Past, Current & Future Analysis for Digital Genomes by Product - Sequencing & Analyzer Instruments, DNA / RNA Analysis Kits, Sequencing Chips, Sequencing & Analysis Software and Sample Preparation Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Asia-Pacific 6-Year Perspective for Digital Genomes by Product - Percentage Breakdown of Value Sales for Sequencing & Analyzer Instruments, DNA / RNA Analysis Kits, Sequencing Chips, Sequencing & Analysis Software and Sample Preparation Instruments for the Years 2025 & 2030
    • TABLE 94: Asia-Pacific Recent Past, Current & Future Analysis for Digital Genomes by End-user - Hospitals, Diagnostic Centers & Forensic Labs, Research Institutes and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 95: Asia-Pacific 6-Year Perspective for Digital Genomes by End-user - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers & Forensic Labs, Research Institutes and Other End-Users for the Years 2025 & 2030
    • TABLE 96: Asia-Pacific Recent Past, Current & Future Analysis for Digital Genomes by Application - Clinical, Forensics, Drug Discovery & Development and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 97: Asia-Pacific 6-Year Perspective for Digital Genomes by Application - Percentage Breakdown of Value Sales for Clinical, Forensics, Drug Discovery & Development and Other Applications for the Years 2025 & 2030
  • REST OF WORLD
    • TABLE 98: Rest of World Recent Past, Current & Future Analysis for Digital Genomes by Product - Sequencing & Analyzer Instruments, DNA / RNA Analysis Kits, Sequencing Chips, Sequencing & Analysis Software and Sample Preparation Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Rest of World 6-Year Perspective for Digital Genomes by Product - Percentage Breakdown of Value Sales for Sequencing & Analyzer Instruments, DNA / RNA Analysis Kits, Sequencing Chips, Sequencing & Analysis Software and Sample Preparation Instruments for the Years 2025 & 2030
    • TABLE 100: Rest of World Recent Past, Current & Future Analysis for Digital Genomes by End-user - Hospitals, Diagnostic Centers & Forensic Labs, Research Institutes and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 101: Rest of World 6-Year Perspective for Digital Genomes by End-user - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers & Forensic Labs, Research Institutes and Other End-Users for the Years 2025 & 2030
    • TABLE 102: Rest of World Recent Past, Current & Future Analysis for Digital Genomes by Application - Clinical, Forensics, Drug Discovery & Development and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 103: Rest of World 6-Year Perspective for Digital Genomes by Application - Percentage Breakdown of Value Sales for Clinical, Forensics, Drug Discovery & Development and Other Applications for the Years 2025 & 2030

IV. COMPETITION